The Critical and Emerging Role of Bank Chief Risk Officers
By Roshni Patel, Global Head of Risk Solutions, Quantexa If you want to understand why…
Risk Management
EPKINLYTM (epcoritamab) Approved by Japan Ministry of Health, Labour and Welfare as the First Bispecific Antibody to Treat Adults Patients with Certain Types of Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)
Media Release Subcutaneous EPKINLYTM (epcoritamab) is the first and only bispecific antibody approved in Japan…
Repligen Appoints Jason K. Garland as Chief Financial Officer
WALTHAM, Mass., Sept. 12, 2023 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company…
Repligen Appoints Jason K. Garland as Chief Financial Officer
WALTHAM, Mass., Sept. 12, 2023 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company…
The Dangers of Public Wi-Fi
Reports suggest that 400 million Americans go on long distance business trips annually, and with…
Genmab and Seagen Announce That TIVDAK® (tisotumab vedotin-tftv) Met its Primary Endpoint of Improved Overall Survival in Patients with Recurrent or Metastatic Cervical Cancer Compared to Chemotherapy
Company Announcement Phase 3 innovaTV 301 confirmatory trial met its primary endpoint of improved overall…
Press Release: Sanofi announces changes to its Executive Committee
Sanofi announces changes to its Executive Committee Paris, August 31st, 2023. Sanofi announces the following…
Press Release: Sanofi announces changes to its Executive Committee
Sanofi announces changes to its Executive Committee Paris, August 31st, 2023. Sanofi announces the following…
Genmab to Present at Morgan Stanley 21st Annual Global Healthcare Conference
Media Release COPENHAGEN, Denmark; August 28, 2023 Genmab A/S (Nasdaq: GMAB) announced today that its…
Shadow IT Risks: How to Safeguard Your Organization & Navigate the Storm
By Ben Pippenger, CSO at Zylo Managing software can pose a real challenge for organizations….
BioNTech Announces Second Quarter 2023 Financial Results and Corporate Update
Significant pipeline advancement highlighted by the initiation of BNT316/ONC-392 Phase 3 pivotal trial and multiple…
Genmab Announces Financial Results for the First Half of 2023
August 3, 2023 Copenhagen, Denmark; Interim Report for the First Six Months Ended June 30,…
Genmab Announces Financial Results for the First Half of 2023
August 3, 2023 Copenhagen, Denmark; Interim Report for the First Six Months Ended June 30,…
Genmab Updates 2023 Financial Guidance
Company Announcement COPENHAGEN, Denmark; July 28, 2023 – Genmab A/S (Nasdaq: GMAB) announced today its…
Genmab Announces AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)
Company Announcement The positive CHMP opinion is supported by results from the EPCORE™ NHL-1 phase…
What to Look for in a Modern Insider Risk Solution
Insider threat can be described as the potential of an employee to utilize their authorised…
Genmab and AbbVie Announce Positive Topline Results from Phase 1/2 EPCORE™ NHL-1 Trial Evaluating Epcoritamab (DuoBody® CD3xCD20) in Patients with Relapsed/Refractory Follicular Lymphoma (FL)
Company Announcement Based on the topline results from the EPCORE™ NHL-1 clinical trial, Genmab and…
Genmab Announces Epcoritamab Added to National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for ‘B-Cell Lymphomas’
Media Release COPENHAGEN, Denmark; June 22, 2023 – Genmab A/S (Nasdaq: GMAB) today announced that…
Amarin Announces Vascepa® (Icosapent Ethyl) Approved to Reduce Cardiovascular Risk in the Kingdom of Saudi Arabia (KSA)
— VASCEPA® Approved in KSA To Reduce the Risk of Cardiovascular (CV) Events as an…
SEED Therapeutics, BeyondSpring Subsidiary, Appoints Jackson Tai to Board of Directors
Former Director at Eli Lilly, HSBC and MastercardBrings Almost Five Decades of Experience in Finance,…